)
Johnson & Johnson vaccines to be restarted in US despite rare clot risk
US has approved to restart of Johnson & Johnson COVID-19 vaccine roll out after scientific advisers decided its benefits outweigh a rare risk of blood clot.
US has approved to restart of Johnson & Johnson COVID-19 vaccine roll out after scientific advisers decided its benefits outweigh a rare risk of blood clot.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)